Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer

Hui-Chen Ku1, Ching-Feng Cheng1,2,3

  • 1Department of Pediatrics, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan.

Frontiers in Endocrinology
|September 14, 2020
PubMed

Insights

Activating transcription factor 3 (ATF3) is a key stress-response protein. This review highlights ATF3's crucial roles in metabolism, immunity, and cancer, suggesting it as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Cancer Biology

Background:

  • Activating transcription factor 3 (ATF3) is a stress-induced transcription factor.
  • ATF3 integrates diverse extracellular signals, including ER stress, cytokines, and LPS.
  • It functions as a central hub in the cellular adaptive-response network.

Purpose of the Study:

  • To review the multifaceted roles of ATF3 in metabolism, immunity, and oncogenesis.
  • To explore ATF3's mechanisms as both a transcriptional activator and repressor.
  • To highlight ATF3's potential as a therapeutic target for metabolic disorders, immune diseases, and cancers.

Main Methods:

  • Literature review focusing on ATF3's regulatory functions.
  • Analysis of ATF3's involvement in glucose and adipose tissue metabolism.
  • Examination of ATF3's role in immune response and host defense.
  • Investigation of ATF3's impact on various cancer types (prostate, breast, colon, lung, liver).

Main Results:

  • ATF3 modulates glucose metabolism and adipose tissue regulation.
  • ATF3 is critical for immune regulation and maintaining host defense.
  • ATF3 plays significant roles in the oncogenesis of multiple cancers.
  • ATF3 regulates signaling pathways crucial for metabolism, immunity, and cancer.

Conclusions:

  • ATF3 acts as a master regulator of metabolic homeostasis.
  • ATF3 is implicated in immune disorders and the progression of various cancers.
  • Targeting ATF3 may offer therapeutic strategies for metabolic dyshomeostasis, immune disorders, and cancer treatment.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K
Master Transcription Regulators02:23

Master Transcription Regulators

2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K